Clinical Trial: Tocilizumab for Relapsing Polychondritis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis

Brief Summary: This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.